these studies confirm it reliably elevates IGF-1 and GH levels in adults with age-related GH insufficiency, but large-scale RCTs supporting its use specifically for injury recovery or tissue repair are lacking, and most recovery-focused data comes from animal models or case series Regulatory / legal status: Not FDA-approved for injury recovery or anti-aging use
Handle in accordance with standard laboratory safety procedures
REDEFINE 1 (Garvey et al., NEJM 2025) is the only Phase 3 trial of an amylin + incretin co-administered combination, pairing cagrilintide 2.4 mg with semaglutide 2.4 mg
Peptide Dosing Protocols editorial team Per-protocol reconstitution math and dosing references for BPC-157, semaglutide, tirzepatide, retatrutide, TB-500, and CJC-1295/Ipamorelin
Retrieved from Caporuscio, J
Semaglutide should be used in conjunction with lifestyle modifications, including a balanced diet and regular exercise